INFLUENCE OF ORAL-CONTRACEPTIVES ON THE INCIDENCE OF PREMALIGNANT AND MALIGNANT LESIONS OF THE CERVIX

被引：24

作者：

ANDOLSEK, L ^{[1
]}

KOVACIC, J ^{[1
]}

KOZUH, M ^{[1
]}

LITT, B ^{[1
]}

机构：

[1] US BUR DRUGS, ROCKVILLE, MD USA

来源：

CONTRACEPTION | 1983年 / 28卷 / 06期

关键词：

D O I：

10.1016/0010-7824(83)90102-6

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：505 / 519

页数：15

共 16 条

[1]

BERGET A, 1978, DAN MED BULL, V25, P172

[2]

BOYCE JG, 1972, OBSTET GYNECOL, V40, P139

[3]

HREN M, 1978, QUADERNI CLIN OBSTET, V33, P1

[4]

KISTNER RW, 1979, GYNECOLOGY PRINCIPLE

[5]

MANTEL N, 1959, J NATL CANCER I, V22, P719

[6]

MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163

[7]

MELAMED M R, 1973, Gynecologic Oncology, V1, P290, DOI 10.1016/0090-8258(73)90021-8

[8]

ORY HW, 1977, PHARM STEROID CONTRA, P211

[9] INCIDENCE OF CERVICAL-CANCER AND DURATION OF ORAL-CONTRACEPTIVE USE [J].

PERITZ, E ;

RAMCHARAN, S ;

FRANK, J ;

BROWN, WL ;

HUANG, S ;

RAY, R .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 106 (06) :462-469

[10] STEROID CONTRACEPTIVE USE AND CERVICAL DYSPLASIA - INCREASED RISK OF PROGRESSION [J].

STERN, E ;

FORSYTHE, AB ;

YOUKELES, L ;

COFFELT, CF .

SCIENCE, 1977, 196 (4297) :1460-1462

← 1 2 →